Template:Antivirals: Difference between revisions

Latest revision as of 02:17, 21 January 2011

Revision as of 16:58, 6 December 2010 view source C Michael Gibson (talk \| contribs) Bureaucrats, nukepages, Administrators 54,243 edits m Reverted edits by Kelvin683601 (Talk) to last version by Cassandra Abueg ← Older edit	Latest revision as of 02:17, 21 January 2011 view source Drsjpdc (talk \| contribs) Bureaucrats, editnews, nocaptcha 599 edits m Reverted edits by Hubert530083 (Talk) to last version by C Michael Gibson
(One intermediate revision by one other user not shown)
(No difference)

v t e Antivirals, other than for HIV (primarily J05, also S01AD and D06BB)
Anti-herpesvirus (DNA, I)	guanine analogues (Aciclovir, Famciclovir, Ganciclovir, Penciclovir, Valaciclovir, Valganciclovir) • nucleoside analogues (Idoxuridine, Trifluridine, Vidarabine) • Cidofovir • Docosanol • Fomivirsen • Foscarnet • Tromantadine
HPV/MC (DNA, I)	Imiquimod • Podophyllotoxin
Hepatitis B (DNA, VII)	Adefovir • Interferon alfa-2b • Pegylated interferon alfa-2a • Entecavir • Lamivudine • Telbivudine • Tenofovir^†
Hepatitis C (RNA, IV)	Pegylated interferon alpha • Ribavirin • Taribavirin^† • Boceprevir^†
Picornavirus (RNA, IV)	Pleconaril^†
Anti-influenza agents (RNA, V)	Arbidol adamantane derivatives/M2 inhibitors (Amantadine, Rimantadine) neuraminidase inhibitors (Oseltamivir, Zanamivir, Peramivir^†)
HIV (Reverse, VI)	See HIV pharm
Other antiviral agents	general (Inosine, Interferon)
^†Undergoing clinical trials, not FDA approved.